{"transactions":[{"id":1419027,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:16:52.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":221600,"price":6.3202,"value":1400556.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.32 to $6.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":3726341,"source":{"system":"sec-edgar","filing":"0000950170-24-102354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000095017024102354/ownership.xml","form_type":"4"}},{"id":2302625,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":false,"shares":11726,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VII GP-GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VII GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP-GP. Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Ventures VII GP-GP, except to the extent of his pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2302624,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":true,"shares":11726,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of Versant Ventures VII GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VII GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VII GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP-GP. Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Ventures VII GP-GP, except to the extent of his pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":11726,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2302623,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":false,"shares":14194,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VII GP to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VII GP. Versant Ventures VII GP-GP is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP. Each of Versant Ventures VII GP-GP and Jerel C. Davis disclaim beneficial ownership of the shares held by Versant Ventures VII GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2302622,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":true,"shares":14194,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures VII GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VII."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VII GP. Versant Ventures VII GP-GP is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP. Each of Versant Ventures VII GP-GP and Jerel C. Davis disclaim beneficial ownership of the shares held by Versant Ventures VII GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":14194,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2302621,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":false,"shares":709953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VII, L.P. (\"Versant VII\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held of record by Versant VII. Versant Ventures VII GP, L.P. (\"Versant Ventures VII GP\") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC (\"Versant Ventures VII GP-GP\") is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant Ventures VII GP-GP, Versant Ventures VII GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2913070,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2444210,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:16:02.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":92000,"price":16.0002,"value":1472018.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Venture Capital VII, L.P. (\"Versant VII\"), Versant Voyageurs I, L.P. (\"Versant Voyageurs I\") and Versant Voyageurs I Parallel, L.P. (\"Versant I Parallel\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are held of record by Versant I Parallel. Versant Voyageurs I GP, L.P. (\"Versant Voyageurs I GP\") is the general partner of Versant I Parallel. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant Voyageurs I GP. Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP, Versant Voyageurs I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant I Parallel, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":552149,"source":{"system":"sec-edgar","filing":"0000899243-22-000946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322000946/doc4.xml","form_type":"4"}},{"id":2444209,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:16:02.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":308000,"price":16.0002,"value":4928061.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Venture Capital VII, L.P. (\"Versant VII\"), Versant Voyageurs I, L.P. (\"Versant Voyageurs I\") and Versant Voyageurs I Parallel, L.P. (\"Versant I Parallel\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by Versant Voyageurs I. Versant Voyageurs I GP Company is the general partner of Versant Voyageurs I. Jerel C. Davis, a member of the Issuer's board of directors, is a director of Versant Voyageurs I GP Company and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I. Each of Versant Voyageurs I GP Company and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Voyageurs I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1863197,"source":{"system":"sec-edgar","filing":"0000899243-22-000946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322000946/doc4.xml","form_type":"4"}},{"id":2444208,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:16:02.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":600000,"price":16.0002,"value":9600120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Venture Capital VII, L.P. (\"Versant VII\"), Versant Voyageurs I, L.P. (\"Versant Voyageurs I\") and Versant Voyageurs I Parallel, L.P. (\"Versant I Parallel\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held of record by Versant VII. Versant Ventures VII GP, L.P. (\"Versant Ventures VII GP\") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC (\"Versant Ventures VII GP-GP\") is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant VII GP-GP, Versant VII GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3623023,"source":{"system":"sec-edgar","filing":"0000899243-22-000946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322000946/doc4.xml","form_type":"4"}},{"id":2585215,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-31T19:06:18.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":78098,"price":14,"value":1093372.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Versant Voyageurs I Parallel L.P. (\"Versant I Parallel\"). Versant Voyageurs I GP, L.P. (\"Versant Voyageurs I GP\") is the general partner of Versant I Parallel. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant Voyageurs I GP. Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP, Versant Voyageurs I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant I Parallel, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":644149,"source":{"system":"sec-edgar","filing":"0000899243-21-034627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924321034627/doc4.xml","form_type":"4"}},{"id":2585214,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-31T19:06:18.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":261902,"price":14,"value":3666628.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by Versant Voyageurs I, L.P. (\"Versant Voyageurs I\"). Versant Voyageurs I GP Company is the general partner of Versant Voyageurs I. Jerel C. Davis, a member of the Issuer's board of directors, is a director of Versant Voyageurs I GP Company and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I. Each of Versant Voyageurs I GP Company and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Voyageurs I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2171197,"source":{"system":"sec-edgar","filing":"0000899243-21-034627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924321034627/doc4.xml","form_type":"4"}},{"id":2585213,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-31T19:06:18.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":510000,"price":14,"value":7140000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held of record by Versant Venture Capital VII, L.P. (\"Versant VII\"). Versant Ventures VII GP, L.P. (\"Versant Ventures VII GP\") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC (\"Versant Ventures VII GP-GP\") is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant VII GP-GP, Versant VII GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4223023,"source":{"system":"sec-edgar","filing":"0000899243-21-034627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924321034627/doc4.xml","form_type":"4"}},{"id":2942831,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T19:04:24.000Z","date":"2020-12-14","kind":"other","acquired":false,"shares":307,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Vantage I GP-GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held Versant Vantage I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-034179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320034179/doc4.xml","form_type":"4"}},{"id":2942830,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T19:04:24.000Z","date":"2020-12-14","kind":"other","acquired":true,"shares":307,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of Versant Vantage I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I GP LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Vantage I GP-GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held Versant Vantage I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":307,"source":{"system":"sec-edgar","filing":"0000899243-20-034179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320034179/doc4.xml","form_type":"4"}},{"id":2942829,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T19:04:24.000Z","date":"2020-12-14","kind":"other","acquired":false,"shares":310,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP LP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Vantage I GP LP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-034179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320034179/doc4.xml","form_type":"4"}},{"id":2942828,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T19:04:24.000Z","date":"2020-12-14","kind":"other","acquired":true,"shares":310,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Vantage I GP LP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Vantage I GP LP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":310,"source":{"system":"sec-edgar","filing":"0000899243-20-034179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320034179/doc4.xml","form_type":"4"}},{"id":2942827,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T19:04:24.000Z","date":"2020-12-14","kind":"other","acquired":false,"shares":20784,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. (\"Versant Vantage I\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":822140,"source":{"system":"sec-edgar","filing":"0000899243-20-034179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320034179/doc4.xml","form_type":"4"}},{"id":2962984,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-30","kind":"other","acquired":false,"shares":463,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F19","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F18","text":"Shares held by Versant Vantage I GP-GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held Versant Vantage I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962983,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-30","kind":"other","acquired":true,"shares":463,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"Represents a change in the form of ownership of Versant Vantage I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I GP LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F18","text":"Shares held by Versant Vantage I GP-GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held Versant Vantage I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":463,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962982,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-30","kind":"other","acquired":false,"shares":467,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP LP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by Versant Vantage I GP LP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962981,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-30","kind":"other","acquired":true,"shares":467,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a change in the form of ownership of Versant Vantage I GP LP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by Versant Vantage I GP LP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":467,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962980,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-30","kind":"other","acquired":false,"shares":31175,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":842924,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962979,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":200,"price":34.1646,"value":6832.92,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by Versant Vantage I, L.P. (\"Versant Vantage I\")."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.77 to $34.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (12) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":874099,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962978,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":10193,"price":33.1286,"value":337679.8198,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by Versant Vantage I, L.P. (\"Versant Vantage I\")."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (10) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":874299,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962977,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-27","kind":"other","acquired":false,"shares":6797,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP-GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VI GP-GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962976,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-27","kind":"other","acquired":true,"shares":6797,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of Versant Ventures VI GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VI GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VI GP-GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":6797,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962975,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-27","kind":"other","acquired":false,"shares":7880,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962974,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-27","kind":"other","acquired":true,"shares":7880,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures VI GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":7880,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2962973,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:13:26.000Z","date":"2020-11-27","kind":"other","acquired":false,"shares":394000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"Versant VI\") to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3947941,"source":{"system":"sec-edgar","filing":"0000899243-20-032389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032389/doc4.xml","form_type":"4"}},{"id":2966316,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":3316,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F24","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I GP LP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F20","text":"Shares held by Versant Voyageurs I GP LP. Bradley J. Bolzon is a partner of Versant Voyageurs I GP LP and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966315,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":true,"shares":2488,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F23","text":"Represents a change in the form of ownership of Versant Voyageurs I GP LP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant I Parallel."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F20","text":"Shares held by Versant Voyageurs I GP LP. Bradley J. Bolzon is a partner of Versant Voyageurs I GP LP and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3316,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966314,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":46121,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F21","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I Parallel, L.P. (\"Versant I Parallel\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F22","text":"Shares held by Versant I Parallel. Versant Voyageurs I GP LP is the general partner of Versant I Parallel. Versant Ventures VI GP is the general partner of Versant Voyageurs I GP LP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":380942,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966313,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":true,"shares":828,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F19","text":"Represents a change in the form of ownership of Versant Voyageurs I GP, L.P. (\"Versant Voyageurs I GP LP\") by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Voyageurs I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F20","text":"Shares held by Versant Voyageurs I GP LP. Bradley J. Bolzon is a partner of Versant Voyageurs I GP LP and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":828,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966312,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":154671,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I, L.P. (\"Versant Voyageurs I\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F18","text":"Shares held by Versant Voyageurs I. Versant Voyageurs I GP Company (\"Versant Voyageurs I GP\") is the general partner of Versant Voyageurs I. Bradley J. Bolzon may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1277541,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966311,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":1258,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by Versant Vantage I GP-GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held Versant Vantage I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966310,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":true,"shares":1258,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a change in the form of ownership of Versant Vantage I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I GP LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by Versant Vantage I GP-GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held Versant Vantage I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1258,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966309,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":1269,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP LP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Shares held by Versant Vantage I GP LP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966308,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":true,"shares":1269,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a change in the form of ownership of Versant Vantage I GP LP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Shares held by Versant Vantage I GP LP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1269,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966307,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":84462,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. (\"Versant Vantage I\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":884492,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966306,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":8223,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP-GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VI GP-GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966305,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":true,"shares":8223,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of Versant Ventures VI GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VI GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VI GP-GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":8223,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966304,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":9533,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966303,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":true,"shares":9533,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures VI GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":9533,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2966302,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T16:49:02.000Z","date":"2020-11-23","kind":"other","acquired":false,"shares":476659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"Versant VI\") to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4341941,"source":{"system":"sec-edgar","filing":"0000899243-20-032169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320032169/doc4.xml","form_type":"4"}},{"id":2970020,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-23T16:41:44.000Z","date":"2020-11-19","kind":"sale","acquired":false,"shares":114854,"price":33.01,"value":3791330.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4818600,"source":{"system":"sec-edgar","filing":"0000899243-20-031918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031918/doc4.xml","form_type":"4"}},{"id":2970019,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-23T16:41:44.000Z","date":"2020-11-19","kind":"sale","acquired":false,"shares":15163,"price":33.01,"value":500530.63,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":968954,"source":{"system":"sec-edgar","filing":"0000899243-20-031918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031918/doc4.xml","form_type":"4"}},{"id":2973314,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:19:10.000Z","date":"2020-11-18","kind":"sale","acquired":false,"shares":473,"price":33.0938,"value":15653.3674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.025 to $33.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4933454,"source":{"system":"sec-edgar","filing":"0000899243-20-031771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031771/doc4.xml","form_type":"4"}},{"id":2973313,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:19:10.000Z","date":"2020-11-18","kind":"sale","acquired":false,"shares":63,"price":33.0938,"value":2084.9094,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.025 to $33.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":984117,"source":{"system":"sec-edgar","filing":"0000899243-20-031771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031771/doc4.xml","form_type":"4"}},{"id":2973312,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:19:10.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":3705,"price":33.0498,"value":122449.509,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4933927,"source":{"system":"sec-edgar","filing":"0000899243-20-031771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031771/doc4.xml","form_type":"4"}},{"id":2973311,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:19:10.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":489,"price":33.0498,"value":16161.3522,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":984180,"source":{"system":"sec-edgar","filing":"0000899243-20-031771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031771/doc4.xml","form_type":"4"}},{"id":2977836,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T19:33:55.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":177,"price":33.0125,"value":5843.2125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4937632,"source":{"system":"sec-edgar","filing":"0000899243-20-031322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031322/doc4.xml","form_type":"4"}},{"id":2977835,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T19:33:55.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":23,"price":33.0125,"value":759.2875,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":984669,"source":{"system":"sec-edgar","filing":"0000899243-20-031322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031322/doc4.xml","form_type":"4"}},{"id":2977834,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T19:33:55.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":1502,"price":34.5309,"value":51865.4118,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $34.715, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4937809,"source":{"system":"sec-edgar","filing":"0000899243-20-031322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031322/doc4.xml","form_type":"4"}},{"id":2977833,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T19:33:55.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":2473,"price":33.3149,"value":82387.7477,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4939311,"source":{"system":"sec-edgar","filing":"0000899243-20-031322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031322/doc4.xml","form_type":"4"}},{"id":2977832,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T19:33:55.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":198,"price":34.5309,"value":6837.1182,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $34.715, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":984692,"source":{"system":"sec-edgar","filing":"0000899243-20-031322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031322/doc4.xml","form_type":"4"}},{"id":2977831,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T19:33:55.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":327,"price":33.3149,"value":10893.9723,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":984890,"source":{"system":"sec-edgar","filing":"0000899243-20-031322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031322/doc4.xml","form_type":"4"}},{"id":2981547,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":353,"price":35.1488,"value":12407.5264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant VI, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (21) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4941784,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981546,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":9450,"price":34.3928,"value":325011.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant VI, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (20) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4942137,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981545,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":3976,"price":33.4774,"value":133106.1424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant VI, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (18) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4951587,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981544,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":47,"price":35.1488,"value":1651.9936,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant VI, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (21) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F19","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":985217,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981543,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":1248,"price":34.3928,"value":42922.2144,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant VI, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (20) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F19","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":985264,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981542,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":524,"price":33.4774,"value":17542.1576,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant VI, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (18) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F19","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":986512,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981541,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":4282,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I GP LP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Shares held by Versant Voyageurs I GP LP. Bradley J. Bolzon is a partner of Versant Voyageurs I GP LP and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981540,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":true,"shares":3211,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"Represents a change in the form of ownership of Versant Voyageurs I GP LP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant I Parallel."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Shares held by Versant Voyageurs I GP LP. Bradley J. Bolzon is a partner of Versant Voyageurs I GP LP and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4282,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981539,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":59534,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I Parallel, L.P. (\"Versant I Parallel\"), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Shares held by Versant I Parallel. Versant Voyageurs I GP LP is the general partner of Versant I Parallel. Versant Ventures VI GP is the general partner of Versant Voyageurs I GP LP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":427063,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981538,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":true,"shares":1071,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a change in the form of ownership of Versant Voyageurs I GP, L.P. (\"Versant Voyageurs I GP LP\") by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Voyageurs I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Shares held by Versant Voyageurs I GP LP. Bradley J. Bolzon is a partner of Versant Voyageurs I GP LP and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I GP LP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1071,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981537,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":199652,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I, L.P. (\"Versant Voyageurs I\"), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares held by Versant Voyageurs I. Versant Voyageurs I GP Company (\"Versant Voyageurs I GP\") is the general partner of Versant Voyageurs I. Bradley J. Bolzon may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1432212,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981536,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":11918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP-GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VI GP-GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981535,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":true,"shares":11918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of Versant Ventures VI GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VI GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VI GP-GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":11918,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981534,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":13816,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981533,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":true,"shares":13816,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures VI GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":13816,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2981532,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T19:47:06.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":690814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"Versant VI\"), to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4955563,"source":{"system":"sec-edgar","filing":"0000899243-20-031061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320031061/doc4.xml","form_type":"4"}},{"id":2984039,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T17:41:55.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":9027,"price":34.9372,"value":315378.1044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.40 to $35.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5646377,"source":{"system":"sec-edgar","filing":"0000899243-20-030855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030855/doc4.xml","form_type":"4"}},{"id":2984038,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T17:41:55.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":2119,"price":33.8596,"value":71748.4924,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.36 to $34.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5655404,"source":{"system":"sec-edgar","filing":"0000899243-20-030855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030855/doc4.xml","form_type":"4"}},{"id":2984037,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T17:41:55.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":1191,"price":34.9372,"value":41610.2052,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.40 to $35.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":987036,"source":{"system":"sec-edgar","filing":"0000899243-20-030855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030855/doc4.xml","form_type":"4"}},{"id":2984036,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T17:41:55.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":280,"price":33.8596,"value":9480.688,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.36 to $34.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":988227,"source":{"system":"sec-edgar","filing":"0000899243-20-030855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030855/doc4.xml","form_type":"4"}},{"id":2984035,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T17:41:55.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":12433,"price":34.1438,"value":424509.8654,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5657523,"source":{"system":"sec-edgar","filing":"0000899243-20-030855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030855/doc4.xml","form_type":"4"}},{"id":2984034,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T17:41:55.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":11388,"price":33.4778,"value":381245.1864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5669956,"source":{"system":"sec-edgar","filing":"0000899243-20-030855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030855/doc4.xml","form_type":"4"}},{"id":2984033,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T17:41:55.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":1642,"price":34.1438,"value":56064.1196,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":988507,"source":{"system":"sec-edgar","filing":"0000899243-20-030855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030855/doc4.xml","form_type":"4"}},{"id":2984032,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T17:41:55.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":1503,"price":33.4778,"value":50317.1334,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":990149,"source":{"system":"sec-edgar","filing":"0000899243-20-030855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030855/doc4.xml","form_type":"4"}},{"id":2986708,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-10T19:24:51.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":5565,"price":33.0556,"value":183954.414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5681344,"source":{"system":"sec-edgar","filing":"0000899243-20-030745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030745/doc4.xml","form_type":"4"}},{"id":2986707,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-10T19:24:51.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":735,"price":33.0556,"value":24295.866,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":991652,"source":{"system":"sec-edgar","filing":"0000899243-20-030745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030745/doc4.xml","form_type":"4"}},{"id":2986706,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-10T19:24:51.000Z","date":"2020-11-06","kind":"sale","acquired":false,"shares":2738,"price":33.1285,"value":90705.833,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5686909,"source":{"system":"sec-edgar","filing":"0000899243-20-030745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030745/doc4.xml","form_type":"4"}},{"id":2986705,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-10T19:24:51.000Z","date":"2020-11-06","kind":"sale","acquired":false,"shares":362,"price":33.1285,"value":11992.517,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":992387,"source":{"system":"sec-edgar","filing":"0000899243-20-030745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030745/doc4.xml","form_type":"4"}},{"id":2989860,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-06T16:44:00.000Z","date":"2020-11-05","kind":"sale","acquired":false,"shares":7816,"price":33.1473,"value":259079.2968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5689647,"source":{"system":"sec-edgar","filing":"0000899243-20-030580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030580/doc4.xml","form_type":"4"}},{"id":2989859,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-06T16:44:00.000Z","date":"2020-11-05","kind":"sale","acquired":false,"shares":1032,"price":33.1473,"value":34208.0136,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":992749,"source":{"system":"sec-edgar","filing":"0000899243-20-030580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030580/doc4.xml","form_type":"4"}},{"id":2989858,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-06T16:44:00.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":2208,"price":33.1357,"value":73163.6256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5697463,"source":{"system":"sec-edgar","filing":"0000899243-20-030580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030580/doc4.xml","form_type":"4"}},{"id":2989857,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-06T16:44:00.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":292,"price":33.1357,"value":9675.6244,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":993781,"source":{"system":"sec-edgar","filing":"0000899243-20-030580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320030580/doc4.xml","form_type":"4"}},{"id":2998717,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-28T17:58:03.000Z","date":"2020-10-27","kind":"sale","acquired":false,"shares":707,"price":33.0325,"value":23353.9775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5699671,"source":{"system":"sec-edgar","filing":"0000899243-20-029546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320029546/doc4.xml","form_type":"4"}},{"id":2998716,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-28T17:58:03.000Z","date":"2020-10-27","kind":"sale","acquired":false,"shares":93,"price":33.0325,"value":3072.0225,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":994073,"source":{"system":"sec-edgar","filing":"0000899243-20-029546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320029546/doc4.xml","form_type":"4"}},{"id":2998715,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-28T17:58:03.000Z","date":"2020-10-26","kind":"sale","acquired":false,"shares":7158,"price":33.3046,"value":238394.3268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5700378,"source":{"system":"sec-edgar","filing":"0000899243-20-029546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320029546/doc4.xml","form_type":"4"}},{"id":2998714,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-28T17:58:03.000Z","date":"2020-10-26","kind":"sale","acquired":false,"shares":945,"price":33.3046,"value":31472.847,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":994166,"source":{"system":"sec-edgar","filing":"0000899243-20-029546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320029546/doc4.xml","form_type":"4"}},{"id":3003014,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:09:32.000Z","date":"2020-10-19","kind":"sale","acquired":false,"shares":3739,"price":33.4309,"value":124998.1351,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5707536,"source":{"system":"sec-edgar","filing":"0000899243-20-028811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320028811/doc4.xml","form_type":"4"}},{"id":3003013,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:09:32.000Z","date":"2020-10-19","kind":"sale","acquired":false,"shares":494,"price":33.4309,"value":16514.8646,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":995111,"source":{"system":"sec-edgar","filing":"0000899243-20-028811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320028811/doc4.xml","form_type":"4"}},{"id":3003012,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:09:32.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":7697,"price":33.5728,"value":258409.8416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5711275,"source":{"system":"sec-edgar","filing":"0000899243-20-028811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320028811/doc4.xml","form_type":"4"}},{"id":3003011,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:09:32.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":1016,"price":33.5728,"value":34109.9648,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":995605,"source":{"system":"sec-edgar","filing":"0000899243-20-028811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320028811/doc4.xml","form_type":"4"}},{"id":3003010,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:09:32.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":2473,"price":33.0343,"value":81693.8239,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5718972,"source":{"system":"sec-edgar","filing":"0000899243-20-028811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320028811/doc4.xml","form_type":"4"}},{"id":3003009,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:09:32.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":327,"price":33.0343,"value":10802.2161,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":996621,"source":{"system":"sec-edgar","filing":"0000899243-20-028811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320028811/doc4.xml","form_type":"4"}},{"id":3006398,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-15T19:22:45.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":4859,"price":33.0906,"value":160787.2254,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":5721445,"source":{"system":"sec-edgar","filing":"0000899243-20-028366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320028366/doc4.xml","form_type":"4"}},{"id":3006397,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":2,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":3,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-15T19:22:45.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":642,"price":33.0906,"value":21244.1652,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. (\"Versant Vantage I\") and Versant Venture Capital VI, L.P. (\"Versant VI\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I. Versant Vantage I GP, L.P. (\"Versant Vantage I GP LP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":996948,"source":{"system":"sec-edgar","filing":"0000899243-20-028366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924320028366/doc4.xml","form_type":"4"}}],"next_cursor":"2020-10-15T19:22:45.000000Z,3006397"}